M. Fussenegger, The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies, Biotechnology Progress, vol.17, issue.1, pp.1-51, 2001.
DOI : 10.1021/bp000129c

U. Baron and H. Bujard, Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances, Meth Enzymol, vol.327, pp.401-421, 2000.
DOI : 10.1016/S0076-6879(00)27292-3

Z. Zhu, T. Zheng, C. Lee, . Homer, and J. Elias, Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling, Seminars in Cell & Developmental Biology, vol.13, issue.2, pp.121-128, 2002.
DOI : 10.1016/S1084-9521(02)00018-6

F. Ginhoux, S. Turbant, . Gross, . Da, J. Poupiot et al., HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system, Molecular Therapy, vol.10, issue.2, pp.279-289, 2004.
DOI : 10.1016/j.ymthe.2004.05.012

V. Rivera, T. Clackson, S. Natesan, R. Pollock, J. Amara et al., A humanized system for pharmacologic control of gene expression, Nature Medicine, vol.90, issue.9, pp.1028-1032, 1996.
DOI : 10.1128/MCB.11.4.1785

V. Rivera, X. Wang, S. Wardwell, . Courage, . Nl et al., Regulation of Protein Secretion Through Controlled Aggregation in the Endoplasmic Reticulum, Science, vol.287, issue.5454, pp.826-830, 2000.
DOI : 10.1126/science.287.5454.826

R. Pollock, R. Issner, K. Zoller, S. Natesan, . Rivera et al., Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector, Proceedings of the National Academy of Sciences, vol.3, issue.7, pp.13221-13226, 2000.
DOI : 10.1007/s0089470030466

R. Vogel, . Mammeri, and J. Mallet, Lentiviral Vectors Mediate Nonimmunosuppressive Rapamycin Analog-Induced Production of Secreted Therapeutic Factors in the Brain: Regulation at the Level of Transcription and Exocytosis, Human Gene Therapy, vol.19, issue.2, pp.167-178, 2008.
DOI : 10.1089/hum.2007.125

M. Nielsen, C. Lundegaard, . Lund, and C. Kesmir, The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage, Immunogenetics, vol.3, issue.1-2, pp.33-41, 2005.
DOI : 10.1093/oxfordjournals.molbev.a025627

M. Nielsen, C. Lundegaard, T. Blicher, K. Lamberth, M. Harndahl et al., NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence, PLoS ONE, vol.18, issue.8, p.796, 2007.
DOI : 10.1371/journal.pone.0000796.s004

C. Lemmel, S. Weik, U. Eberle, J. Dengjel, T. Kratt et al., Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling, Nature Biotechnology, vol.22, issue.4, pp.450-454, 2004.
DOI : 10.1038/nbt947

A. Davis, . Bernstein, . Ps, D. Bok, J. Turner et al., A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture, Invest Ophthalmol Vis Sci, vol.36, pp.955-964, 1995.

F. Fallaux, O. Kranenburg, . Cramer, . Sj, A. Houweling et al., Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral Vectors, Human Gene Therapy, vol.7, issue.2, pp.215-222, 1996.
DOI : 10.1089/hum.1996.7.2-215

A. Weinzierl, D. Rudolf, N. Hillen, S. Tenzer, P. Van-endert et al., Features of TAP-independent MHC class???I ligands revealed by quantitative mass spectrometry, European Journal of Immunology, vol.172, issue.6, pp.1503-1510, 2008.
DOI : 10.4049/jimmunol.172.2.1083

A. Weinzierl, C. Lemmel, O. Schoor, M. Müller, T. Krüger et al., Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface, Molecular & Cellular Proteomics, vol.114, issue.1, pp.102-113, 2007.
DOI : 10.1002/eji.200635910

D. Thommen, H. Schuster, M. Keller, S. Kapoor, . Weinzierl et al., Two Preferentially Expressed Proteins Protect Vascular Endothelial Cells from an Attack by Peptide-Specific CTL, The Journal of Immunology, vol.188, issue.11, pp.5283-5292, 2012.
DOI : 10.4049/jimmunol.1101506

URL : http://www.jimmunol.org/content/jimmunol/188/11/5283.full.pdf

B. Wölk, C. Trautwein, B. Büchele, N. Kersting, . Blum et al., Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands, PLoS ONE, vol.22, issue.1, p.29286, 2012.
DOI : 10.1371/journal.pone.0029286.s002

B. Seliger, . Dressler, . Sp, C. Massa, C. Recktenwald et al., Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells, PROTEOMICS, vol.105, issue.12, pp.2528-2541, 2011.
DOI : 10.1073/pnas.0810676105

V. Meyer, O. Drews, M. Günder, J. Hennenlotter, . Rammensee et al., Identification of Natural MHC Class II Presented Phosphopeptides and Tumor-Derived MHC Class I Phospholigands, Journal of Proteome Research, vol.8, issue.7, pp.3666-3674, 2009.
DOI : 10.1021/pr800937k

V. Meyer, W. Kastenmuller, G. Gasteiger, M. Franz-wachtel, T. Lamkemeyer et al., Long-Term Immunity against Actual Poxviral HLA Ligands as Identified by Differential Stable Isotope Labeling, The Journal of Immunology, vol.181, issue.9, pp.6371-6383, 2008.
DOI : 10.4049/jimmunol.181.9.6371

URL : http://www.jimmunol.org/content/jimmunol/181/9/6371.full.pdf

S. Hacein-bey-abina, C. Von-kalle, M. Schmidt, L. Deist, F. Wulffraat et al., A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency, New England Journal of Medicine, vol.348, issue.3, pp.255-256, 2003.
DOI : 10.1056/NEJM200301163480314

W. Oh, V. Rishi, . Pelech, and C. Vinson, Histological and proteomic analysis of reversible H-Ras V12G expression in transgenic mouse skin, Carcinogenesis, vol.28, issue.10, pp.2244-2252, 2007.
DOI : 10.1093/carcin/bgm127

F. Di-marzo-veronese, D. Arnott, V. Barnaba, . Loftus, . Dj et al., Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects, Journal of Experimental Medicine, vol.183, issue.6, pp.2509-2516, 1996.
DOI : 10.1084/jem.183.6.2509

D. Klionsky, The molecular machinery of autophagy: unanswered questions, Journal of Cell Science, vol.118, issue.1, pp.7-18, 2005.
DOI : 10.1242/jcs.01620

J. Dengjel, O. Schoor, R. Fischer, M. Reich, M. Kraus et al., Autophagy promotes MHC class II presentation of peptides from intracellular source proteins, Proceedings of the National Academy of Sciences, vol.307, issue.5715, pp.7922-7927, 2005.
DOI : 10.1126/science.1108003

S. Malarkannan, T. Horng, . Shih, . Pp, . Schwab et al., Presentation of Out-of-Frame Peptide/MHC Class I Complexes by a Novel Translation Initiation Mechanism, Immunity, vol.10, issue.6, pp.681-690, 1999.
DOI : 10.1016/S1074-7613(00)80067-9

M. Cavazzana-calvo, E. Payen, O. Negre, G. Wang, K. Hehir et al., Transfusion independence and HMGA2 activation after gene therapy of human ??-thalassaemia, Nature, vol.6, issue.7313, pp.318-322, 2010.
DOI : 10.1093/nar/gkn125

URL : https://hal.archives-ouvertes.fr/cea-00905288

W. Humphries, J. Wei, . Sampson, . Heimberger, and . Ab, The Role of Tregs in Glioma-Mediated Immunosuppression: Potential Target for Intervention, Neurosurgery Clinics of North America, vol.21, issue.1, pp.125-137, 2010.
DOI : 10.1016/j.nec.2009.08.012

A. Weinzierl, D. Maurer, F. Altenberend, N. Schneiderhan-marra, K. Klingel et al., A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays, Cancer Research, vol.68, issue.7, pp.2447-2454, 2008.
DOI : 10.1158/0008-5472.CAN-07-2540